USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
08 Dec 2022 | 03:45 PM GMT

Driving Adoption for non-Prescription DTx

Anchored by:

David Matthews
Chief Growth Officer
BRIGHTINSIGHT, INC.

Participants:

David Matthews Chief Growth OfficerBrightInsight, Inc.
David Matthews
Chief Growth OfficerBrightInsight, Inc.
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Ashley Pippin DirectorNovartis
Ashley Pippin
DirectorNovartis
Elisabeth Tsechanski Digital Innovation HubDaiichi Sankyo Europe
Elisabeth Tsechanski
Digital Innovation HubDaiichi Sankyo Europe
Jeff Wandzura CEOKEEP Labs
Jeff Wandzura
CEOKEEP Labs
Jock Thompson CEOHyduro, Inc.
Jock Thompson
CEOHyduro, Inc.
Malin Johansson Vice PresidentNovo Nordisk
Malin Johansson
Vice PresidentNovo Nordisk
Mark Duman Managing Partner/Chief Patient OfficerMD Healthcare Consultants
Mark Duman
Managing Partner/Chief Patient OfficerMD Healthcare Consultants
Nita Thingalaya NA Medical Innovation LeadSanofi
Nita Thingalaya
NA Medical Innovation LeadSanofi
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations. 

 Without adoption, even the best DTx solution will have no impact. As healthcare evolves to a more patient-centric model, DTx products need to be more and more engaging to thrive in this competitive industry. This becomes especially important for non-prescription DTx products, where HCPs are not as actively involved in pushing patient activation and long-term engagement as in prescription DTx.  

Join us in a peer-to-peer conversation where we will discuss: 

  • Effective strategies to involve the patient from early on and leverage patient associations  
  • Patient awareness and activation strategies: what D2C marketing strategies have been successful? 
  • Leverage HCPs recommendations to drive patient adoption in non-prescription DTx 
  • Patient onboarding for non-prescription DTx products: is it the physician job, pharmacists, nurses, patients, or the DTx's customer service?  
  • Long-term patient retention: how to convert patients from acute therapy to maintenance? In behavioral change-based DTx, what are the KPIs for long-term engagement? 
  • Personalization vs. Scaling: is personalization possible when scaling?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.